Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | Breast Cancer Research

Figure 3

From: Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma

Figure 3

Kaplan-Meier estimates for disease-free survival and overall survival by GP88 scores in the validation study. GP88 scores for cases examined were grouped as GP88 < 3+ and GP88 = 3+. Kaplan-Meier survival estimates for DFS and OS were established for the two GP88 groups. A: DFS in high (GP88 = 3+) and lower GP88 score (GP88 < 3+) groups in the training study. B: DFS in high and low GP88 score groups in the validation study. C: OS in high and low GP88 score groups in the training study. D: OS in high and low GP88 score groups in the validation study. E-F: Kaplan-Meier survival estimates for DFS were established for the two GP88 groups in the validation study separated by lymph node status. E: DFS for high and low GP88 groups of lymph node negative cases. F: DFS for high and low GP88 scores of lymph node positive cases.

Back to article page